US Newborn Screening Market to See Key Developments in the Offing, States RNCOS in Its New Study Published at MarketPublishers.com28 Apr 2016 • by Natalie Aster
LONDON – The US newborn screening market is poised to witness a number of developments in the years to come. 93% of the newborn babies are screened for different diseases under the newborn screening test in the country. The US government is taking various steps to make improvements to the quality and effectiveness of these tests. Moreover, the governments of different states are also involved in expanding the tests’ panel.
Blood spot (heel prick) testing is the most extensively performed newborn screening test, with hearing screening and a screening for critical congenital heart disease (CCHD) in newborns, respectively, following after. The technologies utilised for these tests comprise tandem mass spectrometry (MS/MS), pulse oximetry monitoring, immunoassays, electrophoresis and DNA assays. Immunoassay is the most popular technology used owing to the fact that it is included into primary screening tests for newborn babies. Therefore, these tests are anticipated to constantly enjoy increased demand.
The market growth is being fuelled by a number of factors like government funding, surging awareness owing to government incentives, technology advances, and a hike in genetic disorders. Meantime, dearth of consistent regulatory policies in the USA, delays in hospital administration and lack of hospital infrastructure are key challenges to the market.
Some of the prominent players operating in market comprise Perkin Elmer, Natus Medical, Waters Corporation and Agilent Technologies Inc.
New research study “US Newborn Screening Market Outlook 2020” developed by RNCOS E-Services (RNCOS) provides unprejudiced insights into the newborn screening marketplace across the USA, examining it based on tests utilised for screening as well as technologies that support the diagnosis. The report keeps track of the developments in the market taking place over the past couple of years, looks at the drivers and challenges influencing the sector, and assesses the competitive landscape by limelighting the outstanding players. The study offers a careful analysis of the market size, by tests and technologies, for 2014, plus forecasts through to 2020. The report profiles the top players, covering their financials, major products, pertinent developments and a SWOT analysis.
More reports by the publisher can be found at RNCOS page.